GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

Although the first GLP-1 drug was approved by the US Food and Drug Administration (FDA) in the early 2000s, it wasn't until a ...

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

Popular weight-loss therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss.

With great promise also comes the risk of side effects, such as gastrointestinal issues, pancreatitis, and other downsides, when taking GLP-1 drugs. For instance, losing weight on these ...

As Ozempic use rises, some patients report unexpected nasal symptoms, prompting researchers to investigate this new and unusual side effect.

Research shows bimagrumab may prevent muscle and bone loss associated with weight loss medications like Wegovy, offering hope ...

These ‘GLP-1 agonists ... These drugs have unlocked the potential for a global market that is projected to surpass US$100 ...

WEIGHT-loss jabs are taking the world by storm, with a staggering half a million of us now using them. The injections have ...

Doctors say drugs that improve muscle mass could benefit older or infirm people at greater risk of falls and fractures ...

The spot “is a clear violation” of the FDCA, “which requires that advertising for prescription drugs — including compounded ...

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.